27 August 2019 Ankylosing Spondylitis Biologics Conditions Almost one-third of RA patients are taking biologics
16 April 2019 Ankylosing Spondylitis Biologics EULAR Game-changing RA drugs out of Third World’s reach
16 April 2019 Ankylosing Spondylitis Biologics Biosimilar launch will make affordable rituximab a reality
28 March 2019 Analgesics Biologics Conditions Corticosteroids Spondyloarthritis Take only as directed: high-dose Xeljanz poses PE risk
6 March 2019 Ankylosing Spondylitis Biologics Conditions Scleroderma New biologics for psoriatic arthritis
30 August 2018 Biologics Conditions Polymyalgia Rheumatica Not all gout treatments can be considered equal
